RHOEN-KLINIKUM AGRHOEN-KLINIKUM AGRHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪856.81 M‬EUR
‪38.71 M‬EUR
‪1.67 B‬EUR
‪3.65 M‬
Beta (1Y)
0.34
Employees (FY)
‪18.25 K‬
Change (1Y)
+106 +0.58%
Revenue / Employee (1Y)
‪101.17 K‬EUR
Net income / Employee (1Y)
‪2.34 K‬EUR

About RHOEN-KLINIKUM AG


CEO
Tobias Kaltenbach
Headquarters
Bad Neustadt an der Saale
Founded
1973
ISIN
DE0007042301
FIGI
BBG00HMXV4J2
Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RHK is 12.8 EUR — it has increased by 0.79% in the past 24 hours. Watch RHOEN-KLINIKUM AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange RHOEN-KLINIKUM AG stocks are traded under the ticker RHK.
RHK stock hasn't changed in a week, the month change is a −0.78% fall, over the last year RHOEN-KLINIKUM AG has showed a 13.27% increase.
We've gathered analysts' opinions on RHOEN-KLINIKUM AG future price: according to them, RHK price has a max estimate of 12.00 EUR and a min estimate of 12.00 EUR. Watch RHK chart and read a more detailed RHOEN-KLINIKUM AG stock forecast: see what analysts think of RHOEN-KLINIKUM AG and suggest that you do with its stocks.
RHK reached its all-time high on Jan 31, 2018 with the price of 31.7 EUR, and its all-time low was 9.7 EUR and was reached on Feb 7, 2024. View more price dynamics on RHK chart.
See other stocks reaching their highest and lowest prices.
RHK stock is 0.00% volatile and has beta coefficient of 0.34. Track RHOEN-KLINIKUM AG stock price on the chart and check out the list of the most volatile stocks — is RHOEN-KLINIKUM AG there?
Today RHOEN-KLINIKUM AG has the market capitalization of ‪856.81 M‬, it has increased by 1.57% over the last week.
Yes, you can track RHOEN-KLINIKUM AG financials in yearly and quarterly reports right on TradingView.
RHOEN-KLINIKUM AG is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
RHK net income for the last quarter is ‪9.01 M‬ EUR, while the quarter before that showed ‪10.80 M‬ EUR of net income which accounts for −16.51% change. Track more RHOEN-KLINIKUM AG financial stats to get the full picture.
Yes, RHK dividends are paid annually. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 1.17%. Tracking RHOEN-KLINIKUM AG dividends might help you take more informed decisions.
RHOEN-KLINIKUM AG dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.98% and 39.94% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪18.25 K‬ employees. See our rating of the largest employees — is RHOEN-KLINIKUM AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RHOEN-KLINIKUM AG EBITDA is ‪96.33 M‬ EUR, and current EBITDA margin is 2.73%. See more stats in RHOEN-KLINIKUM AG financial statements.
Like other stocks, RHK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RHOEN-KLINIKUM AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RHOEN-KLINIKUM AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RHOEN-KLINIKUM AG stock shows the buy signal. See more of RHOEN-KLINIKUM AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.